Updated:
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001178711, and its reported...
Overview
Paratek Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001178711, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-16, it reported annual revenue of USD 160,268,000; net income of USD -63,566,000; total assets of USD 172,538,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Paratek Pharmaceuticals, Inc.
- Former names in filing history
- Transcept Pharmaceuticals Inc (2008-10-31 to 2014-10-30); NOVACEA INC (2002-07-23 to 2009-01-20)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001178711
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $160.3M | -$63.6M | $172.5M | $34.2M | -$66.1M | |
| FY2021USD | $130.2M | -$59.1M | $183.9M | $80.4M | -$48.3M | |
| FY2020USD | $46.9M | -$96.5M | $176.9M | $105.2M | -$103.4M | |
| FY2019USD | $16.5M | -$128.8M | $251.1M | $102.3M | -$134.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | THE SCHEDULE 13G | |
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| DEF 14A | — | DEFINITIVE PROXY STATEMENT | |
| 10-Q | 10-Q | ||
| 10-K/A | 10-K/A | ||
| SC 13D | — | SCHEDULE 13D | |
| 10-K | 10-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Paratek Pharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.